18F-Fluciclovine PET/MRI for prostate cancer staging, androgen deprivation evaluation
According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), fluorine-18-labeled fluciclovine PET/MRI demonstrated utility…
Browsing: ADT
New Research Finds Low Bone Health Testing Rates after Prostate Cancer Treatment
New research in the October 2020 issue of the Journal of the National Comprehensive Cancer…
ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer
It has been announced that the results from the final analysis of the pivotal Phase…
Prostate cancer survivors more susceptible to chronic diseases
Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the…
Salvage cryoablation shows clinical benefit in delaying hormone therapy for men with locally recurrent prostate cancer
Androgen deprivation therapy (ADT) is commonly administered to many men whose prostate cancer returns after…
Combination immunotherapy effective for advanced prostate cancer
Advanced prostate cancer resistant to castration therapy appears to respond well to a combination of…
Common prostate cancer treatment linked to later dementia
A new retrospective study of patient medical records suggests that men with prostate cancer who…